biotech fireworks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (553)	1/7/2003 12:28:59 PM
From: JMarcus	Read Replies (1) of 7424

DOR also just announced that <<it has executed an exclusive option with the University of Texas Southwestern Medical Center (UT Southwestern) in Dallas to license patent applications pending in the United States and elsewhere pertaining to the use of novel recombinant ricin A chain mutants as vaccines to protect against aerosolized ricin. The exclusive option covers the development of intranasal, oral and inhalable vaccines that can be developed using the proprietary non-toxic mutants of ricin. Ricin is the second most potent toxin known to man. It could be deployed as a weapon by aerosolization, and there is no effective antidote or vaccine approved for human use. Ricin is described by the Centers for Disease Control and Prevention (CDC) as a category B biological agent that could be used as bioterrorist weapons. Lung damage caused by inhalation of ricin toxin is quick and irreversible. Even relatively small-scale use of ricin by terrorists has the capacity to cause widespread disruption and huge expenditures of resources to diagnose and treat ricin exposure and to clean up contamination. >> Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next